share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schneider Jennifer

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schneider Jennifer

福泰製藥 | 4：持股變動聲明-董事 Schneider Jennifer
美股sec公告 ·  05/18 04:25
牛牛AI助理已提取核心訊息
Jennifer Schneider, associated with Vertex Pharmaceuticals Inc. [VRTX], was granted 922 shares of common stock on May 15, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Schneider directly holds a total of 922 shares in the company. The grant represents an increase in Schneider's stake in Vertex Pharmaceuticals, potentially aligning her interests more closely with those of shareholders.
Jennifer Schneider, associated with Vertex Pharmaceuticals Inc. [VRTX], was granted 922 shares of common stock on May 15, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Schneider directly holds a total of 922 shares in the company. The grant represents an increase in Schneider's stake in Vertex Pharmaceuticals, potentially aligning her interests more closely with those of shareholders.
與Vertex Pharmicals Inc. [VRTX] 相關的詹妮弗·施耐德於2024年5月15日獲得922股普通股。根據交易代碼 “A”，交易是在不向接收者支付任何費用的情況下完成的，該交易表示贈款、獎勵或其他收購。在這筆交易之後，施耐德直接持有該公司共922股股份。這筆贈款增加了施耐德在Vertex Pharmicals的股份，這有可能使她的利益與股東的利益更加緊密地保持一致。
與Vertex Pharmicals Inc. [VRTX] 相關的詹妮弗·施耐德於2024年5月15日獲得922股普通股。根據交易代碼 “A”，交易是在不向接收者支付任何費用的情況下完成的，該交易表示贈款、獎勵或其他收購。在這筆交易之後，施耐德直接持有該公司共922股股份。這筆贈款增加了施耐德在Vertex Pharmicals的股份，這有可能使她的利益與股東的利益更加緊密地保持一致。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。